000148457 001__ 148457
000148457 005__ 20250121144847.0
000148457 0247_ $$2doi$$a10.1097/ADM.0000000000000888
000148457 0248_ $$2sideral$$a124928
000148457 037__ $$aART-2022-124928
000148457 041__ $$aeng
000148457 100__ $$aBueno-Antequera, Javier
000148457 245__ $$aExercise Addiction Stability and Health Effects. A 6-Month Follow-up Postcompetition Study in Amateur Endurance Cyclists
000148457 260__ $$c2022
000148457 5060_ $$aAccess copy available to the general public$$fUnrestricted
000148457 5203_ $$aObjective: To study the longitudinal stability of exercise addiction and its health effects in apparently healthy amateur endurance cyclists from pre- to 6-month post-competition.
Methods: In total, 330 (30 women) adult cyclists were divided into 4 groups based on scores on the Exercise Addiction Inventory at both periods: nonrisk (n = 262, 79.1%), transient (n = 35, 10.6%), emerging (n = 14, 4.2%) and persistent (n = 20, 6.1%).
Results: The prevalence of high-risk exercise addiction was reduced postcompetition (16.7% vs 10.3%, P = 0.017). Of the cyclists with a high precompetition risk of exercise addiction, 63.6% (35/55) had a transient addiction associated with favorable effects on mental quality of life (effect size [ES] = 0.52, 95% confidence interval: [0.20, 0.86]) and sleep quality (ES = -0.50 [-0.89, -0.12]) and avoided the worsening of depression symptom severity compared to the remaining groups (ES range = 0.51-0.65). The 5.1% (14/275) of cyclists with a precompetition low risk of exercise addiction presented emerging exercise addiction that was associated with a worsened mental quality of life compared to the remaining groups (ES ranged 0.59-0.91), sleep quality compared to the nonrisk (ES = -0.56 [-0.02, -1.10]) and transient (ES = -0.72 [-1.36, -0.08]) groups and anxiety symptom severity compared to the persistent group (ES = 0.51 [1.20, -0.19]).
Conclusions: Exercise addiction had a marked transitory component at 6-month postcompetition with associated health benefits in amateur endurance cyclists.
000148457 536__ $$9info:eu-repo/grantAgreement/ES/DGA-FEDER-PUI-2018-336$$9info:eu-repo/grantAgreement/ES/DGA-FEDER-PUI-2018-337$$9info:eu-repo/grantAgreement/ES/DGA/S25D17)$$9info:eu-repo/grantAgreement/ES/MEC/FPU13-05130
000148457 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000148457 590__ $$a5.5$$b2022
000148457 591__ $$aSUBSTANCE ABUSE$$b3 / 21 = 0.143$$c2022$$dQ1$$eT1
000148457 592__ $$a1.491$$b2022
000148457 593__ $$aMedicine (miscellaneous)$$c2022$$dQ1
000148457 593__ $$aPsychiatry and Mental Health$$c2022$$dQ1
000148457 593__ $$aPharmacology (medical)$$c2022$$dQ1
000148457 594__ $$a5.7$$b2022
000148457 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000148457 700__ $$aOviedo-Caro, Miguel Ángel
000148457 700__ $$0(orcid)0000-0003-2644-9386$$aLegaz-Arrese, Alejandro$$uUniversidad de Zaragoza
000148457 700__ $$aParis-Garcia, Federico
000148457 700__ $$0(orcid)0000-0001-8951-3643$$aGuillén-Correas, Roberto$$uUniversidad de Zaragoza
000148457 700__ $$aMunguía-Izquierdo, Diego
000148457 700__ $$0(orcid)0000-0003-0721-2447$$aMayolas-Pi, Carmen$$uUniversidad de Zaragoza
000148457 7102_ $$11006$$2245$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Educación Física y Depor.
000148457 773__ $$g16, 3 (2022), e140-e149$$pJournal of Addiction Medicine$$tJournal of Addiction Medicine$$x1932-0620
000148457 8564_ $$s698277$$uhttps://zaguan.unizar.es/record/148457/files/texto_completo.pdf$$yPostprint
000148457 8564_ $$s2093821$$uhttps://zaguan.unizar.es/record/148457/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000148457 909CO $$ooai:zaguan.unizar.es:148457$$particulos$$pdriver
000148457 951__ $$a2025-01-21-14:47:46
000148457 980__ $$aARTICLE